BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gottlieb K, Dawson J, Hussain F, Murray JA. Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials. Gastroenterol Rep (Oxf) 2015;3:91-102. [PMID: 25725041 DOI: 10.1093/gastro/gov006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Segura V, Ruiz-Carnicer Á, Sousa C, Moreno ML. New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options. Nutrients 2021;13:2146. [PMID: 34201435 DOI: 10.3390/nu13072146] [Reference Citation Analysis]
2 Crocker H, Jenkinson C, Peters M. Quality of life in coeliac disease: item reduction, scale development and psychometric evaluation of the Coeliac Disease Assessment Questionnaire (CDAQ). Aliment Pharmacol Ther 2018;48:852-62. [PMID: 30125953 DOI: 10.1111/apt.14942] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
3 Ludvigsson JF, Ciacci C, Green PH, Kaukinen K, Korponay-Szabo IR, Kurppa K, Murray JA, Lundin KEA, Maki MJ, Popp A, Reilly NR, Rodriguez-Herrera A, Sanders DS, Schuppan D, Sleet S, Taavela J, Voorhees K, Walker MM, Leffler DA. Outcome measures in coeliac disease trials: the Tampere recommendations. Gut. 2018;67:1410-1424. [PMID: 29440464 DOI: 10.1136/gutjnl-2017-314853] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 13.3] [Reference Citation Analysis]
4 Kulkarni A, Patel S, Khanna D, Parmar MS. Current pharmacological approaches and potential future therapies for Celiac disease. Eur J Pharmacol 2021;909:174434. [PMID: 34418405 DOI: 10.1016/j.ejphar.2021.174434] [Reference Citation Analysis]
5 Ukleja A. Nutritional Management of Gastrointestinal Diseases. Gastroenterol Clin North Am 2018;47:xv-x. [PMID: 29413028 DOI: 10.1016/j.gtc.2017.12.001] [Reference Citation Analysis]
6 Crocker H, Jenkinson C, Peters M. Quality of life in coeliac disease: qualitative interviews to develop candidate items for the Coeliac Disease Assessment Questionnaire. Patient Relat Outcome Meas 2018;9:211-20. [PMID: 30013408 DOI: 10.2147/PROM.S149238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, Fasano A. Celiac disease: a comprehensive current review. BMC Med. 2019;17:142. [PMID: 31331324 DOI: 10.1186/s12916-019-1380-z] [Cited by in Crossref: 137] [Cited by in F6Publishing: 117] [Article Influence: 45.7] [Reference Citation Analysis]
8 Leonard MM, Weir DC, DeGroote M, Mitchell PD, Singh P, Silvester JA, Leichtner AM, Fasano A. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet. J Pediatr Gastroenterol Nutr. 2017;64:286-291. [PMID: 28112686 DOI: 10.1097/mpg.0000000000001460] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 8.8] [Reference Citation Analysis]
9 Heredia-olea E, Cortés-ceballos E, Serna-saldívar SO. Malting Sorghum with Aspergillus Oryzae Enhances Gluten-Free Wort Yield and Extract. Journal of the American Society of Brewing Chemists 2018;75:116-21. [DOI: 10.1094/asbcj-2017-2481-01] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kim SM, Mayassi T, Jabri B. Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol. 2015;29:425-435. [PMID: 26060107 DOI: 10.1016/j.bpg.2015.05.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
11 Pinto-Sanchez MI, Silvester JA, Lebwohl B, Leffler DA, Anderson RP, Therrien A, Kelly CP, Verdu EF. Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34526700 DOI: 10.1038/s41575-021-00511-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Das P, Gahlot GP, Singh A, Baloda V, Rawat R, Verma AK, Khanna G, Roy M, George A, Nalwa A, Ramteke P, Yadav R, Ahuja V, Sreenivas V, Gupta SD, Makharia GK. Quantitative histology-based classification system for assessment of the intestinal mucosal histological changes in patients with celiac disease. Intest Res. 2019;17:387-397. [PMID: 30996219 DOI: 10.5217/ir.2018.00167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
13 Syage JA, Murray JA, Green PHR, Khosla C. Latiglutenase Improves Symptoms in Seropositive Celiac Disease Patients While on a Gluten-Free Diet. Dig Dis Sci 2017;62:2428-32. [PMID: 28755266 DOI: 10.1007/s10620-017-4687-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
14 Canestaro WJ, Edwards TC, Patrick DL. Systematic review: patient-reported outcome measures in coeliac disease for regulatory submissions. Aliment Pharmacol Ther 2016;44:313-31. [DOI: 10.1111/apt.13703] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
15 Hindryckx P, Levesque BG, Holvoet T, Durand S, Tang CM, Parker C, Khanna R, Shackelton LM, D'Haens G, Sandborn WJ, Feagan BG, Lebwohl B, Leffler DA, Jairath V. Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials. Gut. 2018;67:61-69. [PMID: 27799282 DOI: 10.1136/gutjnl-2016-312762] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
16 Leffler DA, Acaster S, Gallop K, Dennis M, Kelly CP, Adelman DC. A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development. Value Health 2017;20:637-43. [PMID: 28408006 DOI: 10.1016/j.jval.2016.12.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
17 Mccarville JL, Caminero A, Verdu EF. Pharmacological approaches in celiac disease. Current Opinion in Pharmacology 2015;25:7-12. [DOI: 10.1016/j.coph.2015.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
18 Tarar ZI, Zafar MU, Farooq U, Basar O, Tahan V, Daglilar E. The Progression of Celiac Disease, Diagnostic Modalities, and Treatment Options. J Investig Med High Impact Case Rep 2021;9:23247096211053702. [PMID: 34693776 DOI: 10.1177/23247096211053702] [Reference Citation Analysis]
19 Syage JA, Green PHR, Khosla C, Adelman DC, Sealey-Voyksner JA, Murray JA. Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet. GastroHep 2019;1:293-301. [PMID: 32313451 DOI: 10.1002/ygh2.371] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Clifford S, Taylor AJ, Gerber M, Devine J, Cho M, Walker R, Stefani I, Fidel S, Drahos J, Leffler DA. Concepts and Instruments for Patient-Reported Outcome Assessment in Celiac Disease: Literature Review and Experts' Perspectives. Value Health 2020;23:104-13. [PMID: 31952665 DOI: 10.1016/j.jval.2019.07.018] [Reference Citation Analysis]